Bioplus Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 36.35 Cr
as on 16-12-2024
- Paid Up Capital ₹ 3.00 Cr
as on 16-12-2024
- Company Age 20 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 20.60 Cr
as on 16-12-2024
- Revenue 11.48%
(FY 2022)
- Profit -21.70%
(FY 2022)
- Ebitda -16.50%
(FY 2022)
- Net Worth 5.12%
(FY 2022)
- Total Assets 4.09%
(FY 2022)
About Bioplus Life Sciences
The Corporate was formerly known as Bioplus Pharmaceutical Pvt Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 36.35 Cr and a paid-up capital of Rs 3.00 Cr.
The company currently has active open charges totaling ₹20.60 Cr.
Sunjeev Aurora and Sundeep Aurora serve as directors at the Company.
- CIN/LLPIN
U24232KA2004PTC033578
- Company No.
033578
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Mar 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Bioplus Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunjeev Aurora  | Director | 12-May-2008 | Current |
| Sundeep Aurora | Director | 12-May-2008 | Current |
Financial Performance of Bioplus Life Sciences.
Bioplus Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 11.48% increase. The company also saw a substantial fall in profitability, with a 21.7% decrease in profit. The company's net worth moved up by a moderate rise of 5.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bioplus Life Sciences?
In 2022, Bioplus Life Sciences had a promoter holding of 100.00%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 09 Nov 2005 | ₹20.60 Cr | Open |
How Many Employees Work at Bioplus Life Sciences?
Bioplus Life Sciences has a workforce of 276 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bioplus Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bioplus Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
